课题基金 / 基金详情

Mechanisms of Retinopathy of Prematurity: Role of PAR-2 in restoration of retinal microvascular bed

Mechanisms of Retinopathy of Prematurity: Role of PAR-2 in restoration of retinal microvascular bed
早产儿视网膜病变的机制：PAR-2在视网膜微血管床恢复中的作用
批准号：
172044
负责人：
Chemtob Sylvain
金额：
$44.62万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=172044&lang=en
关键词：
Cell Death Endothelium Nitric Oxide Nitrosative Stress Oxidative Stress Retina

项目摘要

项目成果

Chemtob Sylvain的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Retinopathy of prematurity (ROP) is the major serious eye disorder of the child. This condition is associated with long term complications, including strabismus, myopia, abnormal color discrimination, and blindness. ROP evolves from a relatively high extr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
  • 批准号：
    375897
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2017
  • 负责人：
    Chemtob Sylvain
  • 依托单位：
    Universit de Montral
Choroidopathies in retinopathies: pathogenesis and therapeutic discoveries
Regulation of inner retinal vascularization by the novel lactate receptor, GPR81.
Oxygen and brain injury in the newborn: unprecedented role for fatty acid receptors and characterization of potential therapeutics
海外基金